Clinical Trial Update: Sulfonylurea Response in Patients With Diabetes Due to Kir6.2 Mutations [NA]

View source ↗

Summary

Clinical trial update describing the response of patients with Kir6.2 mutation–associated diabetes to sulfonylurea therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Glyburide (glyburide)

Snippet

Sponsor: Royal Devon and Exeter NHS Foundation Trust | Conditions: Diabetes Mellitus | NA | Status: COMPLETED